Chris Masterjohn has Cholesterol: Your Life Depends on It!, another web site pointing out that the war on cholesterol and the push to put people on statins is misguided. The site argues it is actually polyunsaturated fats, not saturated fats or cholesterol, that contribute to heart disease, cancer, liver damage, and aging. He also has a popular blog.
The program was created by wife and husband Melissa Hartwig and Dallas Hartwig in 2009. They both became certified sports nutritionists; he worked as a physical therapist, and she was working at an insurance company during the day and doing nutritional consulting in her spare time. She quit her job to run the Whole30 business in 2010. They co-authored It Starts With Food (2012) and The Whole30: The 30-Day Guide to Total Health and Food Freedom (2015). They separated in 2015. Melissa Hartwig took over the business, and published Food Freedom Forever: Letting Go of Bad Habits, Guilt, and Anxiety Around Food in 2016.
This book has simply changed my life. I know that you aren't supposed to weigh yourself on this program, but weighing myself is a motivator so I decided to skip that rule. It's only been two weeks and already I feel so much better. I am more alert in the mornings and my acid reflex is gone. In addition, my migraines seemed to have disappeared entirely. What is really motivating me is the fact that I lost 15 pounds and 10 overall inches in two weeks. I also love the fact that I have the energy to exercise again. I look forward to continuing this program even after my 30 days are up. I just feel that healthy and energetic! I'll post an update once my 30 days are complete. :)
Transformed cells adapt metabolism to support tumor initiation and progression. Specific metabolic activities can participate directly in the process of transformation or support the biological processes that enable tumor growth. Exploiting cancer metabolism for clinical benefit requires defining the pathways that are limiting for cancer progression and understanding the context specificity of metabolic preferences and liabilities in malignant cells. Progress toward answering these questions is providing new insight into cancer biology and can guide the more effective targeting of metabolism to help patients.